Efficacy of atezolizumab in the treatment of solid tumors with high tumor mutational burden (TMB): A MyPathway study cohort.

被引：0
|
作者：
Hainsworth, John [1 ]
Friedman, Claire F. [2 ]
Kurzrock, Razelle [3 ]
Spigel, David R. [1 ]
Burris, Howard [1 ]
Sweeney, Christopher J. [4 ]
Meric-Bernstam, Funda [5 ]
Wang, Yong [6 ]
Levy, Jonathan [6 ]
Shames, David [6 ]
Schulze, Katja [6 ]
Patel, Arisha [6 ]
Swanton, Charles [7 ]
机构：
[1] Sarah Cannon Res Inst, Nashville, TN USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA
[4] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Genentech Inc, San Francisco, CA 94080 USA
[7] Francis Crick Inst, London, England
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB012
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prognostic and predictive impact of high tumor mutation burden (TMB) in solid tumors: A systematic review and meta-analysis
    McNamara, M. G.
    Jacobs, T.
    Frizziero, M.
    Pihlak, R.
    Lamarca, A.
    Hubner, R.
    Valle, J. W.
    Amir, E.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [22] MyTACTIC: Afficacy and safety of atezolizumab (atezo) plus chemotherapy (chemo) in patients (pts) with advanced unresectable/metastatic solid tumors with high tumor mutational burden (TMB-H) or high microsatellite instability (MSI-H)/deficient mismatch repair (dMMR)
    Spigel, David R.
    Hussein, Maen A.
    Zuniga, Richard
    Mahadevan, Daruka
    Winn, Robert
    Darbonne, Walter C.
    Yoo, Bongin
    Kim, Young
    Whitehead, Zach
    Vanderwalde, Ari M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Comparative molecular analysis between microsatellite instability-high (MSI-H) tumors with high tumor mutational burden (TMB-H) versus MSI-H tumors with TMB-intermediate/low
    Salem, M. E.
    Puccini, A.
    Grothey, A.
    Xiu, J.
    Goldberg, R.
    Kim, E. S.
    Korn, W. M.
    Lenz, H-J.
    Raghavan, D.
    Marshall, J. L.
    Hall, M. J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [24] Tumor Mutation Burden (TMB) is Associated with Improved Efficacy of Atezolizumab in 1L and 2L+NSCLC Patients
    Kowanetz, Marcin
    Zou, Wei
    Shames, David
    Cummings, Craig
    Rizvi, Naiyer
    Spira, Alexander
    Frampton, Garrett
    Leveque, Vincent
    Flynn, Susan
    Mocci, Simonetta
    Shankar, Geetha
    Funke, Roel
    Ballinger, Marcus
    Waterkamp, Daniel
    Chen, Daniel
    Sandler, Alan
    Hampton, Garret
    Amler, Lukas
    Hegde, Priti
    Hellmann, Matthew
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S321 - S322
  • [25] Tumor mutation burden (TMB) is associated with improved efficacy of atezolizumab in 1L and 2L+NSCLC patients
    Griesinger, F.
    Kowanetz, M.
    Zou, W.
    Shames, D. S.
    Cummings, C. A.
    Rizvi, N. A.
    Spira, A.
    Frampton, G.
    Leveque, V.
    Flynn, S.
    Mocci, S.
    Shankar, G.
    Funke, R.
    Ballinger, M.
    Waterkamp, D.
    Chen, D. S.
    Sandler, A.
    Hampton, G.
    Amler, L. C.
    Hedge, P.
    Hellmann, M. D.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 220 - +
  • [26] Penile squamous cell carcinoma (PSCC) with elevated tumor mutational burden (TMB): A genomic landscape study
    Sager, Rebecca A.
    Spiess, Philippe E.
    Li, Roger
    Grivas, Petros
    Kamat, Ashish M.
    Necchi, Andrea
    Pavlick, Dean C.
    Huang, Richard S. P.
    Lin, Douglas I.
    Ross, Jeffrey S.
    Danziger, Natalie
    Jacob, Joseph M.
    Bratslavsky, Gennady
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Genomic evaluation of tumor mutational burden-high (TMB-H) versus TMB-low (TMB-L) metastatic breast cancer to reveal unique mutational features.
    Sammons, Sarah
    Elliott, Andrew
    Force, Jeremy Meyer
    DeVito, Nicholas C.
    Marcom, Paul Kelly
    Swain, Sandra M.
    Tan, Antoinette R.
    Torres, Evanthia T. Roussos
    Zeng, Jia
    Khasraw, Mustafa
    Balko, Justin M.
    Korn, Wolfgang Michael
    Anders, Carey K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Analysis of association between homologous recombination deficiency and tumor mutational burden in solid tumors
    Li, Hua
    Wu, Liqun
    Shou, Tao
    Jiang, Bo
    Zhuang, Li
    Li, Kunsong
    Tan, Xiang
    Guo, Chao
    Guo, Weidong
    Guan, Yan
    Chen, Zheng
    Ding, Xiao
    Guo, Jun
    Du, Zhenfang
    Cui, Qiang
    Che, Yue
    Yao, Ming
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [29] Molecular differences between high and low tumor mutational burden (TMB) across breast cancer (BC) subtypes
    Licata, Luca
    Galbardi, Barbara
    Gyorffy, Balks
    Karn, Thomas
    Sica, Lorenzo
    Rognone, Alessia
    Zucchinelli, Patrizia
    Aldrighetti, Daniela
    Zambelli, Stefania
    Gianni, Luca
    Bianchini, Giampaolo
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [30] Penile squamous cell carcinoma with high and very high tumor mutational burden (TMB): A genomic landscape and "real-world" clinical outcome study
    Jacob, J. M.
    Spiess, P.
    Padua, T. C. D.
    Li, R.
    Grivas, P.
    Huang, R.
    Lin, D. I.
    Danziger, N. A.
    Ross, J. S.
    Li, G.
    Graf, R. P.
    Pavlick, D. C.
    Basnet, A.
    Bratslavsky, G.
    Necchi, A.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S506 - S506
12345